Lower net result than 95% of companies in retail trade. The sector median is €59,222, over 2,459 companies.
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 141 companies had the same profile as MEDEXEL has now. Each dot is one company, two years later.
96.5%
were still trading
1.4%
stopped another way
2.1%
went bankrupt
Medium-sized
20 years or older
solvency under 10%
a small loss
Test of the method
The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.4%
0.5%
3
0.6%
0.6%
4
0.7%
0.8%
5
0.9%
1.0%
6
1.4%
1.6%
7
1.7%
1.8%
8
1.9%
2.0%
9
3.1%
3.3%
10
5.9%
6.4%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 141 companies, not a prediction for MEDEXEL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0440342980
EY reappointed as company auditor
General meeting of 26-06-2024 · Gazette deed
Capital contribution of €7,999,776
Contribution by Name after signing inVisible after signing in · 21,276 new shares · General meeting of 19-12-2023 · Gazette deed
Name hiddenVisible after signing in resigns as mandate holder
Board meeting of 18-10-2023 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
Grey: the largest companies of the sector (retail trade (NACE 47)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as MEDEXEL: retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741). They are comparable in size and age: total assets between €6.2m and €32m, founded between 1957 and 2003.
MEDEXEL has existed since 1990. In 2015 turnover rose from €1.4m to €3.1m and staff from 10.1 to 22.1 full-time equivalents.
Solvency rose in 2025 from -2.7% to 3.1% because of lower debts.
Name hiddenVisible after signing in holds all the shares. In June 2022, the Official Gazette published the appointment of Hidden nameVisible after signing in as managing director.
The company number of MEDEXEL is 0440.342.980. The VAT number is the same number with BE in front: BE 0440.342.980.
Where is MEDEXEL based?
The registered office is at Louis Mettewielaan 74-76, 1080 Molenbeek-Saint-Jean.Company details
What does MEDEXEL do?
According to the KBO register, the main activity is retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses (NACE 47741).
What is the legal form of MEDEXEL?
MEDEXEL is a private limited company (BV).
When was MEDEXEL founded?
MEDEXEL was founded on 19-03-1990.
Is MEDEXEL still active?
Yes, MEDEXEL is an active enterprise in the KBO register.
How many employees does MEDEXEL have?
MEDEXEL had an average of 90.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does MEDEXEL fall under?
In its 2025 annual accounts, MEDEXEL states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of MEDEXEL?
The turnover of MEDEXEL was €10.3m in financial year 2025, according to the filed annual accounts.
Is MEDEXEL profitable?
In financial year 2025, MEDEXEL made a loss of €2.0m.
Where can I find the annual accounts of MEDEXEL?
MEDEXEL filed 35 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDEXEL due?
MEDEXEL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline